ERBB2 and breast cancer: The prognostic significance of lymphocyte infiltration in HR+ HER2- BC is also less clear than in HR-negative and HER2-positive tumors, in which higher percentages of sTIL are associated with better disease-free survival (DFS) and overall survival (OS) [10].